Detalles de la búsqueda
1.
Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics.
J Transl Med
; 22(1): 42, 2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38200511
2.
Stereotactic body radiotherapy for intramedullary metastases: a retrospective series at the Oscar Lambret center and a systematic review.
BMC Cancer
; 21(1): 1168, 2021 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34717570
3.
CXCL13 Positive Cells Localization Predict Response to Anti-PD-1/PD-L1 in Pulmonary Non-Small Cell Carcinoma.
Cancers (Basel)
; 16(4)2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38398098
4.
The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary Study.
Cancers (Basel)
; 16(2)2024 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38254838
5.
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
Oral Oncol
; 148: 106623, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38006691
6.
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments.
Cancer J
; 29(2): 98-101, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36957980
7.
Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study.
Sci Rep
; 13(1): 11065, 2023 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37422576
8.
A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
Radiother Oncol
; 185: 109697, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37169303
9.
Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study.
JTO Clin Res Rep
; 4(12): 100602, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38124790
10.
A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study.
Cancers (Basel)
; 15(15)2023 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568646
11.
The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy.
Cancer Treat Res Commun
; 37: 100767, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37832364
12.
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.
Lung Cancer
; 178: 116-122, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36812760
13.
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.
Front Oncol
; 13: 1196414, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37546399
14.
Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges.
Am Soc Clin Oncol Educ Book
; 42: 1-14, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35486888
15.
Stereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC).
Clin Transl Radiat Oncol
; 33: 115-119, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35243022
16.
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.
Oncoimmunology
; 11(1): 2096535, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35832043
17.
The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review.
Radiother Oncol
; 156: 1-9, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33137398
Resultados
1 -
17
de 17
1
Próxima >
>>